Latest News & Features
Biotechnology
In future, the more efficient targeting of treatments to specific patient populations that will actually benefit from them, could offset the price of more expensive but well targeted and effective treatments that will be suitable for increasingly smaller patient populations. Daniel Lim and Anna Jackson of Kirkland & Ellis explain. 8 August 2019
Big Pharma
A subsidiary of Akebia Therapeutics has entered into a settlement agreement with Endo-owned Par Pharmaceutical. 7 August 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria. 7 August 2019
article
Hooper, Lundy and Bookman has appointed Andrew Woodmansee to head up a new IP practice at the firm. 7 August 2019
Big Pharma
A subsidiary of Irish pharmaceutical company Allergan is to pay a combined total of $2.7 million to three organisations that were part of an antitrust class against the drugmaker. 6 August 2019
Big Pharma
The European Union has asked the World Trade Organization to establish a panel on Turkey’s measures on pharmaceutical products. 5 August 2019
Americas
Tensions appear to be running high in the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley (UC Berkeley) over which first invented the CRISPR gene-editing technology. 2 August 2019
Americas
Canadian pharmaceutical company Bausch Health and generics maker Teva have resolved their dispute over Apriso (mesalazine), a drug used to treat ulcerative colitis and Crohn's disease. 2 August 2019
Americas
In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries. 1 August 2019
Biotechnology
Exact Sciences will acquire Genomic Health in a merger deal worth $2.8 billion. 31 July 2019